Oncternal Therapeutics, Inc.
Oncternal Therapeutics, Inc. (ONCT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ONCT · as of Jun 9, 2026
Key Statistics
Explore Oncternal Therapeutics, Inc. Data
onct stock data · financialsCompetitors & Peers
onct competitorsONCT
ASLN
AVGR
CMAX
CWBR
NBSEAbout Oncternal Therapeutics, Inc.
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating cancer treatments for diseases where current medical options are insufficient. Its clinical-stage portfoli…
what is oncternal therapeutics, inc. · onct stock overview · oncternal therapeutics, inc. company profile · who is oncternal therapeutics, inc. ceo · onct NASDAQ · oncternal therapeutics, inc. headquarters · oncternal therapeutics, inc. business segments
About Stock Overview & Key Data
Oncternal Therapeutics, Inc. (ONCT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 3, 2004. As of the latest trading session, ONCT stock price is $0.53, with a market capitalization of $1.6M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Oncternal Therapeutics, Inc. (ONCT) stock price is $0.53. The stock is traded on NASDAQ under the ticker symbol ONCT. The 52-week range is $0.53 – $10.61.